These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6124534)

  • 21. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
    Bona JR
    J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of beta-adrenergic blocking agents in anxiety disorders and schizophrenia.
    Hayes PE; Schulz SC
    Pharmacotherapy; 1983; 3(2 Pt 1):101-17. PubMed ID: 6134273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
    Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L
    Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in tardive dyskinesia and MMPI scores with propranolol.
    Novac A
    J Clin Psychiatry; 1986 Apr; 47(4):218-9. PubMed ID: 3957889
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose propranolol in tardive dyskinesia.
    Bacher NM; Lewis HA
    Am J Psychiatry; 1980 Apr; 137(4):495-7. PubMed ID: 6102439
    [No Abstract]   [Full Text] [Related]  

  • 29. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract]   [Full Text] [Related]  

  • 32. Propranolol, anxiety, and tardive dyskinesia.
    Bacher NA; Lewis HA
    J Clin Psychiatry; 1983 May; 44(5):196. PubMed ID: 6133849
    [No Abstract]   [Full Text] [Related]  

  • 33. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clozapine in severe tardive dyskinesia: a case report.
    Meltzer HY; Luchins DJ
    J Clin Psychopharmacol; 1984 Oct; 4(5):286-7. PubMed ID: 6149239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam in tardive dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
    Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
    Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H; Dufresne RL; Weber SS; McCalley-Whitters M
    Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tardive dyskinesia (review of the literature)].
    Lerner VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):124-32. PubMed ID: 2897750
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of propranolol in treating tardive dyskinesia.
    Roberts PW
    Can Med Assoc J; 1980 Dec; 123(11):1106-7. PubMed ID: 7459752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.